Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective – Clinical Rheumatology

We described the profile and outcome of Filipino patients with inflammatory rheumatic diseases (IRDs) who developed COVID-19 (IRD-C19) during the onset of the pandemic, prior to vaccinations and variants. We obtained de-identified data of Filipino patients with IRD-C19 from the Global Rheumatology Alliance registry from March 2020 to August 2021. Descriptive statistics and multivariate analyses…

Read the full article here

Source: SpringerLink

Categories: Hem/Oncs, Latest Headlines

Tweets with this article

Dr. Geraldine Zamora

Really don’t believe in unlucky Friday the 13th!🫶 Do you? Finally published today, after submitting 1 yr ago! Outcomes of Filipinos w/ inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective https://t.co/Ja0B0Wuhkb

Pre-Registration for Lourdes Manahan Lectures in Rheumatology 2024

This form was created inside of University of the Philippines. Report

Dr. Geraldine Zamora April 14, 2024

Bempedoic Acid: A Contemporary Review of Its Pharmacology, Efficacy, and Safety Profile, Including Recent Data from the CLEAR Outcomes Clinical Trial – Current Cardiology Reports

Purpose of Review To provide an updated review of bempedoic acid’s clinical application in lowering LDL-C in the setting of statin intolerance and the recent…

National Lipid Assoc October 5, 2023

Is Metabolic Surgery Having an Identity Crisis? – Obesity Surgery

Obesity Surgery –

Neil Floch MD August 16, 2023

Intrahepatic Balloon Tamponade for Penetrating Liver Injury: Rarely Needed but Highly Effective – World Journal of Surgery

Background Severe penetrating liver injuries are associated with high rates of morbidity and mortality. The objective of this study was to demonstrate the 15-year experience…

Elliott R Haut, MD, PhD August 10, 2023

Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience – Journal of Neuro-Oncology

Purpose Belzutifan is a selective inhibitor of hypoxia-inducible factor 2 alpha (HIF-2a) that has emerged as a targeted therapy option for Von Hippel–Lindau (VHL) syndrome-associated…

Journal of Neuro-Oncology August 2, 2023

Performance Adaptations to Intensified Training in Top-Level Football – Sports Medicine

Because physical demands are surging in football (soccer, USA), clubs are more and more seeking players who have a high capacity to perform repeated intense…

Sports Medicine July 30, 2023

Vasculitis

Tune in to the Filipino Skin: A series to highlight skin findings in inflammatory rheumatic diseases among Filipinos. Part 1: “Lupus” (SLE, Systemic Lupus Er…

Dr. Geraldine Zamora July 22, 2023

Improvement in visual outcomes of patients with base of skull meningioma as a result of evolution in the treatment techniques in the last three decades: a systematic review – Journal of Neuro-Oncology

Purpose We systematically reviewed visual outcomes over the last three decades in patients undergoing treatment for base of skull (BOS) meningiomas and provide recommendations to…

Journal of Neuro-Oncology July 18, 2023

The role of vaccines in the COVID-19 pandemic: what have we learned? – Seminars in Immunopathology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged late in 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic that has so far claimed approximately…

Florian Krammer July 18, 2023

Prospective phenotyping of CHAMP1 disorder indicates that coding mutations may not act through haploinsufficiency – Human Genetics

CHAMP1 disorder is a genetic neurodevelopmental condition caused by mutations in the CHAMP1 gene that result in premature termination codons. The disorder is associated with…

Medical Xpress July 18, 2023

Related Articles